Description
Semaglutide Injection 2 mg by Novo Nordisk is a prescription medication indicated for improving glycemic control in adults with type 2 diabetes mellitus. As a GLP-1 (glucagon-like peptide-1) receptor agonist, it helps the body regulate blood sugar by stimulating insulin release when glucose levels are elevated, reducing glucose production by the liver, and slowing gastric emptying.
Administered as a once-weekly injection, Semaglutide 2 mg provides convenient, long-lasting blood sugar management for adults who require ongoing treatment. When combined with a balanced diet, regular exercise, and other lifestyle modifications, it can help lower HbA1c levels and improve overall diabetes management. In appropriate patients, it may also contribute to weight reduction as part of a comprehensive treatment plan.
Semaglutide Injection 2 mg should only be used under the supervision of a qualified healthcare professional. It is not intended for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis. Always follow your prescribed dosing schedule and your healthcare provider’s instructions.
Additional information
| Pack Size | 1 Vial, 2 Vial, 3 Vial, 5 Vial, 10 Vial |
|---|
